Cardioprotection From Cardiotoxicity

Cardioprotection From Cardiotoxicity

Bibliographic Details
Main Author:	Guilherme H. Oliveira, MD, MBA
Format:	Article
Language:	English
Published:	Elsevier 2019-09-01
Series:	JACC. CardioOncology
Subjects:	anthracyclines cardioprotection cardiotoxicity chemotherapy meta-analysis trastuzumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666087319300353

Similar Items

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
by: Muthiah Vaduganathan, MD, MPH, et al.
Published: (2019-09-01)

Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
by: Xinyi Li, et al.
Published: (2021-08-01)

Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review
by: Simona Serini, et al.
Published: (2017-12-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
by: George E. G. Kluck, et al.
Published: (2020-04-01)

Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review
by: Izabela Koss-Mikołajczyk, et al.
Published: (2021-09-01)

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
by: Sarju Ganatra, et al.
Published: (2019-01-01)

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
by: Lori M. Minasian, MD, et al.
Published: (2019-09-01)

Cardiovascular toxicities from systemic breast cancer therapy
by: Shuang eGuo, et al.
Published: (2014-12-01)

RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS
by: N. T. Vatutin, et al.
Published: (2017-10-01)

Efficacy of Physical Exercise to Offset Anthracycline‐Induced Cardiotoxicity: A Systematic Review and Meta‐Analysis of Clinical and Preclinical Studies
by: Willeke R. Naaktgeboren, et al.
Published: (2021-09-01)

Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity
by: Derek J. Hausenloy, MD, PhD, et al.
Published: (2020-03-01)

Cardio-Оncology – New Challenge in Clinical Practice
by: Sladjana Popović, Srdjan Popović, Nikolina Dukić, Jelena Vladičić-Mašić, Olivera Čančar
Published: (2020-06-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

Left Ventricular Regional Wall Motion Abnormality is a Strong Predictor of Cardiotoxicity in Breast Cancer Patients Undergoing Chemotherapy
by: Márcio Vinícius Lins de Barros, et al.
Published: (2018-12-01)

Cardiotoxicity of cancer therapeutics: current issues in screening, prevention and therapy
by: Richard Joseph Sheppard, et al.
Published: (2013-03-01)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
by: Yili Zhang, et al.
Published: (2020-05-01)

Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure
by: Nadine Norton, et al.
Published: (2020-08-01)

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
by: John Henderson, et al.
Published: (2021-08-01)

Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
by: Caroline J. Zeiss, et al.
Published: (2019-08-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
by: Alexandr T. Teplyakov, et al.
Published: (2017-10-01)

The diagnosis of anthracycline-induced cardiac damage and heart failure
by: Jarosław Dudka, et al.
Published: (2009-05-01)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I
by: Chazova I.Ye., et al.
Published: (2017-09-01)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I
by: I Ye Chazova, et al.
Published: (2017-12-01)

Assessment of anthracycline-induced long-term cardiotoxicity in patients with hematological malignancies
by: Aws Sabah Al-Rubaye, et al.
Published: (2019-01-01)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity
by: David S. Monahan, et al.
Published: (2021-08-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Physical activity during and after breast cancer therapy and associations of baseline physical activity with changes in cardiac function by echocardiography
by: Jenica N. Upshaw, et al.
Published: (2020-09-01)

The effect of anthracyclines in minimal doses on cardiac function of children under chemotherapy
by: Shiva Rahimi Dehgolan, et al.
Published: (2014-07-01)

POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER
by: Yu. V. Vasyuk, et al.
Published: (2017-05-01)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01)

Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy
by: Anita Piasek, et al.
Published: (2009-04-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Effect of traditional Chinese medicine on anthracycline-induced cardiotoxicity in animal models: A systematic review and meta-analysis
by: Xiaoguang Lu, et al.
Published: (2021-01-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Cannot write session to /tmp/vufind_sessions/sess_g4vbc61hpd90t9p4k3vg5mapaj